4
Changes in Ownership
Faeth Therapeutics, Inc. Filed Acc 0002111813-26-000009
President and CEO acquired 761,428 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Parikh Anand Kiran President and CEO | 2026-06-15 | Conversion | +761,428 | 761,428 | D: show line 1 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Parikh Anand Kiran President and CEO | 2026-06-15 | Conversion · Series B Preferred Stock | −761.43 | 0 | D: show line 2 in the form |
Loading xslF345X06/form4-06162026_080634.xml…